[26G-pm] Cancer-2

Sat. Mar 26, 2022 3:42 PM - 4:54 PM [Room G] Exhibition Room 212 (Bldg. 2: 1F)

Chair: Tomoka Takatani-Nakase

+Add all to schedule

3:42 PM - 3:54 PM

[26G-pm12] Ferroptosis sensitivity of SLUG-transduced EMT cells

○Yu Kato¹, Yukari Fukazawa¹, Shingo Kondo¹, Yoshikazu Sugimoto¹ (1. Div. Chemother., Facul. Pharm., Keio Univ.)

3:54 PM - 4:06 PM

[26G-pm13] Integrated analysis of resistance mechanisms to CHK1 and WEE1 inhibitors

○Shingo Kondo¹, Ken Okuda¹, Riho Saito¹, Yu Kato¹, Yoshikazu Sugimoto¹ (1. Div. Chemother., Facul. Pharm., Keio Univ.)

4:06 PM - 4:18 PM

[26G-pm14] SOX10 regulates melanoma immunogenicity through an IRF4-IRF1 axis.

○Satoru Yokoyama¹, Atsushi Takahashi¹, Ryota Kikuchi¹, Soshi Nishibu¹, Yue Zhou¹, Yoshihiro Hayakawa², Hiroaki Sakurai¹ (1. Grad. Sch. Pharm. Sci., Univ. Toyama, 2. Inst. Nat. Med., Univ. Toyama)

4:18 PM - 4:30 PM

[26G-pm15] Increased myeloid cells in cancer exacerbate anaphylaxis to anti-PD-L1 antibodies.

○Takahiro Arai¹, Tomomi Kokubo¹, Ruihen Tang¹, Hirohito Abo¹, Jotaro Hirakawa¹, Hidetaka Akita^1,2, Hiroto Kawashima¹, Akihiro Hisaka¹, Hiroto Hatakeyama¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Pharm. Sci., Tohoku Univ.)

4:30 PM - 4:42 PM

[26G-pm16S] pH-low insertion peptide detects acidic environment in metastatic niche

○Toma Matsui¹, Yuki Toda¹, Ryota Nakai¹, Aoi Yokogawa¹, Rina Itagaki¹, Shigekuni Hosogi¹, Eishi Ashihara¹ (1. Kyoto Pharm. Univ.)

4:42 PM - 4:54 PM

[26G-pm17S] Mechanism of the nuclear receptor PXR-mediated suppression of epithelial-mesenchymal transition of liver cancer cells

○Takumi Sato¹, Ryota Shizu^1,2, Ryonosuke Baba², Mai Ishimura², Takuomi Hosaka^1,2, Takamitsu Sasaki², Yuichiro Kanno^1,2, Kouichi Yoshinari^1,2 (1. Grad. Sch. Integ. Pharm. Nutr. Sci., Univ of Shizuoka, 2. Sch. Pharm. Sci., Univ of Shizuoka)

Session information